Invesco Biotechnology & Genome ETF

Frequently Asked Questions About PBE

What does PBE invest in?

The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. The Index is constructed to achieve capital appreciation by thoroughly evaluating companies based on several investment criteria, including their price momentum, earnings growth, overall quality, management decisions, and valuation. It consists of 30 U.S.-based companies within the biotechnology and genome sectors. These companies are primarily involved in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, or they are businesses that stand to gain significantly from scientific and technological breakthroughs in biotechnology and genetic engineering. Both the ETF and its benchmark index undergo quarterly rebalancing and reconstitution in February, May, August, and November.

What is the expense ratio of PBE?

Invesco Biotechnology & Genome ETF (PBE) charges an expense ratio of 0.59%. This is the annual fee deducted from fund assets to cover management and operations.

How big is PBE?

Invesco Biotechnology & Genome ETF (PBE) manages $412.3M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is PBE actively managed or an index fund?

PBE's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was PBE launched?

Invesco Biotechnology & Genome ETF (PBE) launched in June 2005 and is managed by Invesco.

How has PBE performed?

PBE's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.